Mylan And Biocon’s Semglee Insulin Glargine Approved In US

Product Deemed A Biologic By FDA; Launch May Be Imminent

 
• By Dean Rudge
  
Lantus
Semglee 'has an identical amino acid sequence to Lantus,' Mylan underlined • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin